Dasatinib hydrochloride
CAS: 854001-07-3
Ref. 3D-EJB00107
| 25mg | 136.00 € | ||
| 50mg | 167.00 € | ||
| 100mg | 236.00 € | ||
| 250mg | 353.00 € | ||
| 500mg | 496.00 € |
Product Information
Dasatinib is a tyrosine kinase inhibitor that inhibits the activity of several receptor tyrosine kinases, including c-Kit, PDGFRA, and PDGFRB. Dasatinib was developed for the treatment of acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and other cancers. It is marketed in capsule form as a solution for oral administration. Dasatinib is insoluble in water but soluble in aqueous solutions with pH below 7.5. Dasatinib has been shown to be effective against liposome-encapsulated cancer cells, which may be due to its inhibition of extracellular liposomes.
Chemical properties
Technical inquiry about: 3D-EJB00107 Dasatinib hydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
